S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(-0.80%) $83.18
Gas
(1.14%) $1.945
Gold
(-0.28%) $2 340.70
Silver
(0.11%) $27.57
Platinum
(0.66%) $928.20
USD/EUR
(-0.27%) $0.932
USD/NOK
(-0.32%) $10.99
USD/GBP
(-0.35%) $0.798
USD/RUB
(0.25%) $92.11

Echtzeitaktualisierungen für CSL Ltd [CSL.AX]

Börse: ASX Industrie: Pharmaceuticals, Biotechnology & Life Sciences
Zuletzt aktualisiert29 Apr 2024 @ 06:00

-0.09% $ 273.05

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 06:00):

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally...

Stats
Tagesvolumen 164 583
Durchschnittsvolumen 725 457
Marktkapitalisierung 131.95B
EPS $0 ( 2024-02-13 )
Last Dividend $1.621 ( 2023-03-09 )
Next Dividend $0 ( N/A )
P/E 34.83
ATR14 $0.0970 (0.04%)

Volumen Korrelation

Lang: 0.00 (neutral)
Kurz: 0.48 (neutral)
Signal:(43.757) Neutral

CSL Ltd Korrelation

10 Am meisten positiv korreliert
10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

CSL Ltd Korrelation - Währung/Rohstoff

The country flag -0.63
( weak negative )
The country flag -0.53
( weak negative )
The country flag 0.00
( neutral )
The country flag -0.69
( moderate negative )
The country flag -0.22
( neutral )
The country flag 0.43
( neutral )

CSL Ltd Finanzdaten

Annual 2023
Umsatz: $19.59B
Bruttogewinn: $9.47B (48.33 %)
EPS: $6.92
FY 2023
Umsatz: $19.59B
Bruttogewinn: $9.47B (48.33 %)
EPS: $6.92
FY 2022
Umsatz: $14.47B
Bruttogewinn: $7.68B (53.05 %)
EPS: $6.63
FY 2021
Umsatz: $10.27B
Bruttogewinn: $5.80B (56.49 %)
EPS: $5.22

Financial Reports:

No articles found.

CSL Ltd Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$1.758
(N/A)
$0
(N/A)
$1.621
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

CSL Ltd Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.26 - Increase likely (45.22%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.0167 1994-11-08
Last Dividend $1.621 2023-03-09
Next Dividend $0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 59 --
Total Paid Out $28.07 --
Avg. Dividend % Per Year 0.00% --
Score 4.48 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 7.26
Div. Directional Score 9.64 --
Next Divdend (Est)
(2024-06-24)
$0 Estimate 0.00 %
Dividend Stability
0.10 Very Bad
Dividend Score
4.48
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for ASX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
LBL.AX Ex Dividend Knight 2023-09-07 Semi-Annually 0 0.00%
STO.AX Ex Dividend Knight 2023-08-28 Semi-Annually 0 0.00%
COS.AX Ex Dividend Knight 2023-10-19 Semi-Annually 0 0.00%
MYS.AX Ex Dividend Junior 2023-08-23 Annually 0 0.00%
WGB.AX Ex Dividend Junior 2023-10-12 Semi-Annually 0 0.00%
ENN.AX No Dividend Player 2023-06-29 Annually 0 0.00%
PE1.AX Ex Dividend Junior 2023-07-03 Semi-Annually 0 0.00%
AMH.AX Ex Dividend Knight 2023-08-04 Annually 0 0.00%
GWA.AX Ex Dividend Knight 2023-08-18 Semi-Annually 0 0.00%
RHI.AX No Dividend Player 2023-07-10 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1801.5006.419.61[0 - 0.5]
returnOnAssetsTTM0.06961.2007.689.21[0 - 0.3]
returnOnEquityTTM0.1561.5009.3810.00[0.1 - 1]
payoutRatioTTM0.450-1.0005.50-5.50[0 - 1]
currentRatioTTM2.150.8004.253.40[1 - 3]
quickRatioTTM0.9710.8009.007.20[0.8 - 2.5]
cashRatioTTM0.2161.5009.9110.00[0.2 - 2]
debtRatioTTM0.282-1.5005.30-7.95[0 - 0.6]
interestCoverageTTM6.971.0008.538.53[3 - 30]
operatingCashFlowPerShareTTM8.342.007.2210.00[0 - 30]
freeCashFlowPerShareTTM3.592.008.2110.00[0 - 20]
debtEquityRatioTTM0.612-1.5007.55-10.00[0 - 2.5]
grossProfitMarginTTM0.4841.0005.265.26[0.2 - 0.8]
operatingProfitMarginTTM0.2441.0007.127.12[0.1 - 0.6]
cashFlowToDebtRatioTTM0.2611.0009.669.66[0.2 - 2]
assetTurnoverTTM0.3880.800-0.748-0.599[0.5 - 2]
Total Score12.02

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM34.661.0006.600[1 - 100]
returnOnEquityTTM0.1562.509.6010.00[0.1 - 1.5]
freeCashFlowPerShareTTM3.592.008.8010.00[0 - 30]
dividendYielPercentageTTM1.3931.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM8.342.007.2210.00[0 - 30]
payoutRatioTTM0.4501.5005.50-5.50[0 - 1]
pegRatioTTM7.921.50010.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1901.0007.750[0.1 - 0.5]
Total Score7.26

CSL Ltd

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

Über Live-Signale

Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.

Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.